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Abstract
Rhythmic oscillations of neuronal populations, generated by different mechanisms, are present at several levels of the central nervous system and serve many 
important physiological or reflect pathological functions. Understanding the role of brain oscillations as possible biomarkers of brain function and plasticity is still a 
challenge, and despite extensive research, their role is still not well established.
We recently demonstrated that the hallmarks of earlier aging onset during impaired thalamo-cortical cholinergic innervation (in a rat model of Parkinson’s disease 
cholinopathy) were consistently expressed, from 3 and one half to 5 and one half months of age, through increased electroencephalographic (EEG) sigma activity 
amplitude during rapid eye movement (REM) sleep, as a unique aging induced REM sleep phenomenon. In addition, there was altered motor cortical drive during 
non-rapid-eye-movement (NREM) and REM sleep. 
In order to explain this new aging-induced REM sleep phenomenon, we analyzed possible differences between control REM sleep spindle activity and REM sleep 
spindle activity at the onset of REM sleep “enriched“ with sigma activity (at 4 and one half months of age), following bilateral pedunculopontine tegmental nucleus 
(PPT) cholinergic neuronal loss in the rat. We analzyed differences in spindle density, duration, and frequency. 
We demonstrated in young adult Wistar rats with the severely impaired PPT cholinergic innervation the alterations in sleep spindle dynamics and pattern during 
REM sleep in the motor cortex as the earliest biomarkers for the onset of their altered aging processes.
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Introduction 
Rhythmic oscillations of neuronal populations, generated by 
different mechanisms, are present at several levels of the central 
nervous system and serve many important physiological functions such 
as hippocampal theta activity, occipital alpha waves, and sleep spindles 
[1]. Rhythmic oscillations may also underlie the basis of behavioral 
states, as well as neurological diseases such as epileptic convulsions 
or rhythmic movement disorders [2]. There are an increasing number 
of reports on the association between sleep spindles and alterations 
in diseases such as schizophrenia [3], Parkinson’s disease [4], REM 
sleep behavioral disorder [4,5], Alzheimer’s disease [6,7], autism [8], 
mental retardation [9], memory consolidation, intelligence [10], sleep 
preservation [11], and with recovery processes following brain 
stroke [12].
Understanding the role of brain oscillations as possible biomarkers 
of brain function and plasticity is still a challenge, and despite extensive 
research, their role is still not well established. Sleep spindles, as the 
hallmark of NREM sleep, are EEG oscillations in the sigma frequency 
range, that last, as the waxing and waning oscillations from 0.5-3.0 s 
[13]. Sleep spindles are generated by complex interactions between 
GABAergic neurons of thalamic reticular nucleus (RT) and thalamo-
cortical (TC) nuclei, and are synchronized across multiple thalamic 
nuclei via neocortical feedback [14]. Since sleep spindles result from 
interactions between thalamic reticular, talamo-cortical, hippocampal, 
and cortical neurons, their characteristics may reflect the integrity of 
these circuits or serve as biomarkers of their dysregulation [15].
Our recent study showed that the hallmark of earlier aging onset 
in a rat model of Parkinson’s disease cholinopathy were consistently 
expressed, from 3 and one half to 5 and one half months of age, through 
the increased EEG sigma activity amplitude during REM sleep, as a 
unique aging-induced REM sleep phenomenon. In addition, there was 
altered motor cortical drive during NREM and REM sleep [16]. 
In order to explain this new aging-induced REM sleep phenomenon, 
in this study we analyzed possible differences between control REM 
sleep spindle activity and REM sleep spindle activity at the onset of 
REM “enriched“ with sigma activity (at 4 and one half months of 
age), following bilateral PPT cholinergic neuronal loss in the rat. We 
analzyed differences in spindle density, duration, and frequency.
Materials and methods
We performed the experiments in 36 adult male Wistar rats, 
chronically instrumented for sleep recording at the age of 2 and one 
half months, and randomly assigned to two experimental groups: 
physiological controls (n = 18), and bilateral PPT lesioned rats (n = 18). 
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Prior to surgery and throughout the experimental protocol, the 
animals were maintained on a 12 h light-dark cycle, and were housed 
at 25ºC with free access to food and water. All experimental procedures 
were in compliance with EEC Directive 2010/63/EU on the protection 
of animals used for experimental and other scientific purposes, 
and were approved by Ethical Committee for the Use of Laboratory 
Animals of the Institute for Biological Research “Sinisa Stankovic”, 
University of Belgrade (Approval No 2-21/10).
Surgical procedure
The surgical procedures employed for the EEG and EMG electrode 
implantation for chronic sleep recording and bilateral PPT lesion have 
been described previously [16-24], and are outlined below.
We implanted under ketamine/diazepam anesthesia (Zoletil 
50, VIRBAC, France, 50 mg/kg; i.p.), in 2 and one half months old 
rats, 2 epidural stainless steel screw electrodes for EEG cortical 
activity from the motor cortex (A/P: +1.0 mm from bregma; R/L: 
2.0 mm from sagittal suture; D/V: 1.0 mm from the scull surface) 
[25]. Bilateral electromyogram (EMG) stainless steel teflon coated 
wire electrodes (Medwire, NY, USA) were implanted into the dorsal 
nuchal musculature to assess skeletal muscle activity, and a stainless 
steel screw electrode in the nasal bone as a ground. All the electrode 
leads were soldered to a miniature connector plug (39F1401, Newark 
Electronics, Schaumburg, IL, USA), and the assembly was fixed to the 
screw electrodes and skull using acrylic dental cement (Biocryl-RN, 
Galenika a.d. Beograd, Serbia).
During the surgical procedure for implantation of the EEG and 
EMG electrodes, we performed bilateral PPT lesions. The excitotoxic 
lesions were induced using stereotaxically guided microinfusion of 0.1 
M ibotenic acid (IBO)/0.1 M phosphate buffered saline bilaterally into 
the PPT (A/P: -7.8 mm from bregma; R/L: 1.9 mm from the sagittal 
suture; D/V: 7.0 mm from the brain surface) [25], using a Digital Lab 
Standard Stereotaxic Instrument with Hamilton syringe (1 µl).
The IBO (Sigma; pH = 7.4) concentration was chosen on the 
basis of previous studies [16,18,20,23,26]. The microinfusions were 
introduced at a volume of 100 nl, using a single, 60 s pulse. Following 
microinfusion, the Hamilton syringe was left within the local brain 
tissue for 5 min before removal from the brain, allowing the IBO 
solution to diffuse. After removal from one side of the brain, the needle 
of Hamilton syringe was always washed using saline, and then it was 
inserted again into the PPT on the other side of the brain, for the next 
IBO microinfusion.
Sleep recording and data analysis
Following two weeks of postoperative recovery, we recorded 
spontaneous sleep during 6 h of normal inactive circadian phase 
for rats (from 9 a.m. to 3 p.m.). The EEG and EMG activities were 
displayed on a computer monitor, and stored on disk for further off-
line analysis. Briefly, after conventional amplification and filtering 
(0.3 – 100 Hz band pass; A-M System Inc. Model 3600, Calborg, WA, 
USA), the analog data were digitized (at a sampling frequency of 256/s) 
using DataWave Sci Works Experimenter Version 8.0 (DataWave 
Technologies, Longmont, CO, USA). For the analysis of sleep and 
sleep spindles, we used sleep recordings of the 3 months and 4 and one 
half months old rats at the onset of aging-induced REM sleep disorder 
(REM “enriched” with sigma activity within the motor cortex along 
with severely altered motor cortical drive) in the PPT lesioned rats, as 
previously described [16]. 
The analysis of the recorded signals was conducted using software 
developed in MATLAB 6.5 [16,18-23], and upgraded to MATLAB 
R2011a. We applied Fourier analysis to signals acquired throughout 6 
h (2160 10 s Fourier epochs), and each 10 s epoch was differentiated, 
on the basis of EEG and EMG, as Wake, NREM, or REM sleep state 
(Figure 1). The differentiation of all Wake/NREM/REM sleep epochs 
was improved by using the logarithmic values of the quantities on both 
EEG and EMG axes, and was finally achieved using the two cluster K 
means algorithm [16,18-23]. 
In order to additionally demonstrate that the differentiation of the 
NREM/REM sleep epochs were done in the same way in the control and 
the PPT lesioned rats, we used scattergrams of the linear correlations 
of sigma and theta relative amplitudes, as the EEG hallmarks for light 
NREM and REM sleep (Figure 2). 
To analyze REM sleep EEG microstructure, we calculated the 
group probability density distributions of all conventional EEG 
frequency bands relative amplitudes over 6 h, using the Probability 
Density Estimate (PDE) routine supplied by MATLAB R2011a 
[16,18-20,22-24].
Additionally, we analyzed the REM sleep corticomuscular 
coherence (CMC) for each experimental group at each age, and for all 
the conventional EEG frequency bands, using the EEG from the motor 
cortex and the EMG of the dorsal nuchal muscles [16,21]. The CMC 
values were calculated using the “cohere” routine of the MATLAB 
R2011a Signal Processing Tool box [16,21].
In order to identify sleep spindles (SS) at the onset of REM sleep 
“enriched” with sigma activity within the motor cortex, alongside 
severely altered motor cortical drive in PPT lesioned rats at 4 and one 
half months of age, we combined automatic SS detection with visual 
validation of all detected SS for their final visual extraction (Figure 3). 
Namely, the first step for automatic SS detection during REM sleep 
was to concatenate all the extracted 10 s epochs of REM sleep from 
motor cortex for each rat, each experimental group, and then to filter 
the EEG signals using the 11 - 17 Hz band pass filter. Then, we applied 
the Continuous Wavelet Transform with the mother wavelet “cmorl-2“ 
MATLAB R2011a function, providing a complex Morlet wavelet with 
determined central frequency f0= 2 [27]. In addition, all SS had a 
minimal duration of 0.5 s. 
Since we automatically detected many false positive SS, we visually 
corrected the automatically detected SS, and visually extracted them 
for each REM sleep episode of each rat, and each experimental group 
(n = 7 for controls; n = 5 for PPT lesioned rats), and then concatenated 
all SS for each group of rats. Finally, for the analysis of SS dynamics at 
the onset of REM sleep “enriched” with sigma activity within the motor 
cortex, we used the assembly of 842 SS extracted from 7 control rats, 
and the assembly of 1216 SS extracted from 5 PPT lesioned rats.
All statistical analyses were done using the Kruskal Wallis ANOVA 
with post hoc Mann Whitney U test. For the statistical analysis of 
PDE/6 h and CMC/6 h during REM sleep episode, we calculated the 
means for every 30 min.
Tissue processing and histochemistry for the PPT lesion 
verification
We identified the PPT lesion using NADPH diaphorase histo 
chemistry [28]. The rats were deeply anesthetized and perfused 
transcardially, starting with a vascular rinse until the liver had been 
cleared (200 ml of 0.9% saline; perfusion speed of 40 ml/min); followed 
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by a 4% paraformaldehyde solution in 0.1 M PBS (200 ml; 100 ml 
at 40 ml/min, and then 30 ml/min), and finally with a 10% sucrose 
solution in 0.1 M PBS (200 ml; 30 ml/min). The animals were sacrificed, 
perfused, and the brains were extracted, cleared of the meninges and 
blood vessels, and immersed in 4% paraformaldehyde overnight, and 
then in 30% sucrose solution for several days. The brains were cut in 
a coronal plane into 40 μm-thick sections using a cryotome, and the 
free-floating sections were stained, mounted, and coverslipped with 
DPX (Sigma), and then examined under a Zeiss Axiovert microscope 
equipped with a camera. Briefly, the free-floating sections were rinsed 
in 0.1 M PBS, pH = 7.4, and incubated for 1 h at 37ºC in the staining 
solution – a mixture of the substrate solution with β-nicotinamide 
adenine dinucleotide phosphate, reduced Na4 salt (β-NADPH, Serva), 
and dimethyl sulfoxide (DMSO, Sigma). The substrate solution 
contained dissolved nitro blue tetrazolium chloride (NBT, Serva), and 
5bromo-4chloro-3indolyl phosphate (BCIP, Serva) in the substrate 
buffer at pH = 9.5 (0.1 M Tris, 100 mM NaCl, 5 mM MgCl2). To reduce 
the background staining from endogenous alkaline phosphate, the 
specific inhibitor levamisole (Sigma) was added to the staining solution 
to produce a final concentration of 2 mM [16,18,22].
All the tissue samples of both experimental groups were grouped 
into three defined stereotaxic ranges of the PPT rostro-caudal 
dimension. We quantified the cholinergic cell loss using Image J 1.46 
software. NADPH diaphorase-positive cells were counted in three 40 
μm coronal sections within the overall PPT rostro-caudal dimension. 
The number of NADPH-diaphorase positively stained cells was 
intended to provide an estimate of the lesion damage or the cholinergic 
neuronal numbers, rather than an attempt to determine the absolute 
numbers of cholinergic neurons. The cholinergic neuronal loss was 
expressed for each side of the brain and for each defined stereotaxic 
range within the PPT rostro-caudal dimension, as the percent 
difference of NADPH diaphorase-positive cells versus the controls. To 
be specific, all the percentage differences were expressed with respect to 
the mean control absolute numbers for each stereotaxic range, which 
was taken as 100% [16,18,22]. 
Figure 1. Examples of scattergrams of the Wake/NREM/REM sleep 10 s epochs during 6 h of sleep recordings and across aging (at 3 months and 4 and one half months of age) within 
the motor cortex of control (upper panels) and PPT lesioned rats (bottom panels). The Wake 10 s epochs were only transferred to these final scattergrams from the preceding Wake/Sleep 
differentiation, using the product of EEG sigma and theta frequency power on the y-axis and the total EMG power on the x-axis. W – Wake cluster dots (Wake 10 s epochs); NR – NREM 
cluster crosses (NREM 10 s epochs); R – REM cluster circles (REM 10 s epochs).
Ciric J (2017) Sleep spindles as an early biomarker of REM sleep disorder in a rat model of Parkinson’s disease cholinopathy
Transl Brain Rhythmicity, 2017         doi: 10.15761/TBR.1000111  Volume 2(1): 4-11
Results
Figure 1 depicts the individual examples of Wake/NREM/REM 
sleep 10 s epochs differentiation on the basis of EEG and EMG, 
during 6 h of sleep recordings (2160 Fourier 10 s epochs) in control 
(upper panels) and PPT lesioned rat (bottom panels), at 3 months 
(left panels) and 4 and one half months (right panels) age. In addition, 
by using the scattergrams of linear correlations of sigma and theta 
relative amplitudes, as the EEG hallmarks for light NREM and REM 
sleep (Figure 2), we were able to demonstrate that differentiation of 
the NREM/REM sleep 10 s epochs were done in the same way in the 
controls and the PPT lesioned rats. These scattergrams were typically 
the same for the NREM and REM sleep in controls (upper panels) and 
PPT lesioned rats (middle panels). For the analyses of SS dynamics 
alteration during REM sleep of the PPT lesioned rats versus controls 
(Figure 3 in Materials and Methods), following automatic detection 
(Figure 3, upper panels), we visually corrected SS detection (Figure 3, 
bottom panels), and extracted all SS with a minimal duration of 0.5 s.
We demonstrated that there was no progression of cholinergic 
neuronal loss from 3 months up to 5 and one half months of age, 
following bilateral PPT lesion (Figure 4A). Namely, this permanent 
cholinergic neuronal loss within the PPT versus controls was, for each 
side of the brain ≥ 23.17 ± 2.74% throughout the overall rostro-caudal 
PPT dimension (from 6.90 to 8.60 mm caudal to bregma), with the 
highest decrease ≥ 31.78 ± 2.33% rostrally (from 6.90 to 7.40 mm 
caudal to bregma). A representative example of histological verification 
of cholinergic neuronal loss throughout the overall rostro-caudal PPT 
dimension versus control PPT of one side of the brain is shown in 
Figure 4B.
Figure 2. Differentiation of NREM/REM 10 s epoch based on the linear correlation of relative sigma and theta amplitudes in controls (two upper panels) and PPT lesioned rats (middle 
panels) at 4 and one half months of age, and their overlapped scatter plots (two bottom panels). In both experimental groups (Controls vs. PPT lesion), there were always a consistent negative 
theta/sigma correlations during REM vs. NREM sleep. 
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Figure 3. Individual examples of filtered (11-17 Hz band pass filter) and concatenated EEG signals from the motor cortex of control (A, left panel) and PPT lesioned rat (A, right panel) 
during overall REM sleep per 6 h of sleep recording, with automatic detection of sleep spindles (A, red), and their examples of analog (B, upper panels) and filtered (B, bottom panels) 10 s 
epochs used for visual correction of automatic sleep spindle detection, and their final extraction from the signal. 
This partial but selective bilateral PPT lesion augmented EEG 
sigma amplitude within the motor cortex during REM sleep, with an 
onset from 4 and one half months of age (Figure 5A, B; z = -3.299; 
p= 0.001). This EEG sigma amplitude augmentation was followed by 
augmented correlations between theta, sigma, and beta oscillations of 
EEG from the motor cortex and EMG from the dorsal nuchal muscles 
(Figure 5C; z ≥ -5.66, p ≤ 10-4). In addition, this augmented EEG 
sigma activity during REM sleep in PPT lesioned rats was presumably 
influenced by the significantly increased SS density in the motor cortex 
(Figure 6A, B; z = -2.12; p= 0.03). Namely, whereas the control mean SS 
density during REM sleep in 4 and one half months old rats was 0.016 
± 0.003/ 6 h, it was 0.037 ± 0.009/6 h in PPT lesioned rats (Figure 6B 
left panel). Along with the higher SS density, the PPT lesion induced SS 
of more complex pattern (Figure 6A bottom panels; the sleep spindles 
with mixed intrinsic frequency components), prolonged their mean 
duration, and reduced their mean intrinsic frequency (Figure 6B, C; z 
≥ -10.45, p ≤ 10-3) during REM sleep.Whereas the control means for SS 
duration and intrinsic frequency/6 h, during REM sleep were 1.097 ± 
0.020 s and 13.562 ± 0.029 Hz, their means following PPT lesion were 
1.271 ± 0.019 s and 13.183 ± 0.020 Hz, respectively.
Discussion
We have shown in young adult Wistar rats with reduced PPT 
cholinergic output the alterations in sleep spindle dynamics and pattern 
during REM sleep in the motor cortex as the earliest biomarkers for the 
onset of their altered aging processes.
Apart from altered sleep spindle dynamics (density, duration, 
intrinsic frequency) during REM sleep (Figure 6), the distinct 
aging onset in the rat model of Parkinson’s disease cholinopathy 
was manifested as altered EEG microstructure in the motor cortex 
(augmented sigma amplitude during REM sleep) along with severely 
altered motor cortical drive (augmented correlations between theta, 
sigma, and beta oscillations of EEG and EMG activity) during REM 
sleep (Figure 5).
The term “biomarker” is defined as a “characteristic that is objectively 
measured and evaluated as an indicator of normal biological processes, 
pathogenic processes, or pharmacologic responses to a therapeutic 
intervention” [29]. Also, the term “biomarker” is extensively used in 
sleep research and sleep medicine [30]. Generally, EEG oscillations 
are the most widely used biomarkers of sleep processes and vigilance 
states, and for example, beta activity (15-35 Hz) is not only a marker of 
arousal during active wakefulness, but also reflects sleep drive during 
quiet wakefulness [31]. EEG alpha activity (8-12 Hz), as the most 
distinctive EEG pattern of wakefulness, in particular when the eyes 
are closed, characterizes also the transition from wakefulness to sleep, 
arousal from sleep, and presents an indicator of neurodegeneration 
[32].
On the other hand, REM sleep behavior disorder (RBD), as the 
strongest clinical predictor for the onset of neurodegenerative diseases 
[33,34], presents a unique opportunity to study the progression of 
neurodegenerative diseases and to develop neuroprotective therapies 
for their prevention [35,36]. This unique parasomnia, characterized by 
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Figure 4. Topography of cholinergic neuronal loss across aging (at 3 and 5 and one half months of age) throughout the rostro-caudal dimension of the PPT (A), expressed as the mean 
group percent differences + SE of the NADPH diaphorase-positive cells, where the control absolute number of PPT cholinergic neurons, for each stereotaxic level, was taken as 100% (for 
3 months n = 10 for controls and n = 9 for the PPT lesioned rats; for 5 and one half months n = 8 for controls, and n = 9 for the PPT lesioned rats); and the individual examples of the PPT 
lesion identification throughout the rostro-caudal PPT dimension vs. control PPT, for each brain side (B). Scale bar for all panels is 200 µm.
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Figure 5. The onset of differing impact of aging on the EEG microstructure during REM sleep in the motor cortex of PPT lesioned rats vs. control rats at 3 months (A, left panel, n = 14 
for the control; n = 14 for the PPT lesioned rats), and at 4 and one half months of age (A, right panel, n= 10 for the control; n = 9 for the PPT lesioned rats). The group probability density 
distributions of the EEG sigma relative amplitude/6 h during REM sleep showed an age related augmentation of sigma amplitude within the motor cortex in the PPT lesioned rats vs. control 
rats (the right shifted red distribution) (A). Individual examples of REM spectrograms of the motor cortex in a PPT lesioned rat vs. a control rat at 3 months and at 4 and one half months 
of age (B). For the REM sleep spectrograms the EEG 10 s epochs during REM sleep were extracted and concatenated in the same order as they occurred in real-time during the whole 6 h 
sleep of each rat, at each condition and age. The group mean coherence spectra between the EEG from motor cortex and the dorsal nuchal muscle EMG during REM sleep in PPT lesioned 
rats vs. controls (C) at 3 months (C, left panel) and at 4 and one half months (C, right panel) of age. p values and red arrows correspond to the obtained significant result of Mann-Whitney 
U two-tailed test (p ≤ 10-3). 
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Figure 6. Sleep spindle (SS) dynamics during REM sleep in the motor cortex of PPT lesioned rats (n = 5) vs. controls (n = 7) at 4 and one half months of age (at the onset of REM sleep, 
the EEG was “enriched” (C) with sigma activity, see Fig. 5A). Individual examples of the analog 10 s epochs with visually detected sleep spindles of distinct pattern, duration, and intrinsic 
frequency (A) in a control (upper panels), and a PPT lesioned rat (bottom panels), with the group histograms of their mean SS density, duration, and intrinsic frequency per 6 h + SE (B), 
and the group distributions of all SS durations (SSdur) and intrinsic frequencies (SSf) of the assembly of 842 SS extracted from 7 control rats vs. the assembly of 1216 SS extracted from 5 
PPT lesioned rats. (C) p values correspond to the obtained significant result of Mann-Whitney U two-tailed test.
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loss of normal skeletal muscle atonia and dream enactment behavior 
during REM sleep [37,38,39] very frequently go unnoticed in patients 
with neurodegenerative diseases, and as a symptom precedes the 
onset of motor and cognitive disturbances by years or even decades 
[34,40,41]. Although RBD can be triggered pharmacologically [42], 
it is generally related to structural lesions within the midbrain and 
pontomedullary brainstem, with the consequent disinhibited control 
of the motor cortex to the limbs, likely bypassing the basal ganglia 
or other modulatory structures [34,38,42,43]. In humans, RBD can 
be associated with pontomedullary strokes [34], narcolepsy, limbic 
encephalitis, Guillain-Barre syndrome, pharmacological agents 
(tricyclic or serotonergic antidepressants, alcohol or beta blockers), 
and with many neurodegenerative diseases including progressive 
supranuclear palsy, corticobasal syndrome, frontotemporal dementia, 
and Huntington’s disease [42]. In addition, idiopathic RBD is most 
often caused by one of the synuclein-mediated neurodegenerative 
diseases (Parkinson’s disease, Lewy body dementia, and multiple 
system atrophy), and more than 80% of patients with RBD eventually 
develop one of these diseases [44].
In addition, anatomical studies support the central role of the PPT 
in controlling REM sleep phenomena [45,46], and show that direct 
projections from PPT reach both the basal forebrain and the thalamus 
[47], and therefore the PPT represents a higher control relay nucleus 
for the integrated contributions of the brain cholinergic system to the 
regulation of cortical activation[48,49]. Moreover, based on a number 
of the animal studies [50-52], the PPT has become the main target for 
deep brain stimulation for the treatment of movement and postural 
disorders in humans [53]. PPT as the main brain source of thalamo-
cortical cholinergic innervation has an important functions relevant 
to the regulation of REM sleep [54,55], arousal [55,56], and various 
motor control systems [53,57], including breathing control [58-60]. 
In addition, in relation to motor and cognitive function control, 
particularly in relation to Parkinson’s disease, the PPT is postulated 
as an important interface between the basal ganglia and cerebellum 
[61]. In addition, recent human studies demonstrated that cortical and 
thalamic subcortical cholinergic denervation due to the degeneration 
of PPT cholinergic neurons were related to RBD [62], as well as to gait 
and balance impairment, including falls in Parkinson’s disease [63,64].
Our previous studies demonstrated, in the rat model of severely 
impaired cholinergic thalamo-cortical innervation (our rat model 
of Parkinson’s disease cholinergic neuropathology or Parkinson’s 
disease cholinopathy), topographically differentially expressed EEG 
microstructure within the sensorimotor and motor cortex during 
NREM and REM sleep, along with the appearance of two REM 
sleep states, particularly within the motor cortex [18,19]. Moreover, 
these distinct REM states were differentiated with regard to: EEG 
microstructure, EMG power, and sensorimotor and motor cortical 
drive to the dorsal nuchal muscles [20]. These altered cortical drives 
were commonly expressed during both REM states as impaired beta 
oscillation drive, but the sensorimotor cortical drive was altered more 
severely during “normal” REM sleep (REM sleep with atonia, theta 
REM sleep) than during “pathological” REM sleep (REM sleep without 
atonia, sigma REM sleep). In addition, the hallmarks of an earlier aging 
onset during reduced thalamo-cortical cholinergic innervation were 
consistently expressed through increased EEG sigma amplitude in the 
motor cortex during REM sleep, as a unique REM sleep phenomenon, 
along with altered motor cortical drive (expressed as augmented delta, 
theta, sigma, and beta oscillations from the motor cortex that are 
related to the EMG activity of dorsal nuchal muscles) during NREM 
and REM sleep [16]. 
Therefore, our recent studies suggest that certain sleep disorders, 
particularly REM sleep disorders, depict the potential functional 
biomarkers of neurodegeneration, that are relevant to Parkinson’s 
disease and other synucleinopathies, and the biomarkers of an earlier 
aging onset in the brain with neurodegeneration versus physiologically 
healthy brain. 
Results of our previous studies in animal models are in accordance 
with recent PET imaging studies in humans which demonstrated 
thalamic cholinergic denervation in Parkinson’s disease with or 
without dementia in contrast to Alzheimer’s disease, and suggested that 
the neurodegenerative involvement of thalamic cholinergic afferent 
projections may contribute to disease specific motor and cognitive 
abnormalities [62,64,65].
In addition, there is increasing evidence in human [66,67] and 
animal studies [68,69] that abnormally synchronized oscillatory 
activity in the cortico-basal ganglia loop is associated with the motor 
deficits in Parkinson’s disease, particularly beta synchronization (14-
30 Hz) and high voltage spindles (5-13 Hz). Our present results in the 
rat model of Parkinson’s disease cholinopathy are in accordance with 
evidence that dopamine depletion in 6-OHDA lesioned rats increase 
the density and duration of the high voltage spindles, as a particular 
pattern of spindle activity that also reflects the state of thalamo-cortical 
regulatory network [68]. 
Sleep spindles are one of the basic thalamo-cortical EEG oscillations 
that classically contribute to sleep promotion and maintenance, and 
are associated to sensory gating, motor representation development, 
cognition, and memory consolidation [70]. Spindle frequency is 
basically determined by the interplay of GABAergic inhibitory neurons 
of the RT nucleus and the TC neurons, their intrinsic properties, and 
their influence by cortical descending and the brainstem ascending 
inputs. The duration of IPSPs imposed by RT neurons on TC neurons 
determines the intra-spindle frequency [70]. 
Since PPT cholinergic afferents inhibit RT neurons, the increased 
density of slower and longer sleep spindles within the motor cortex 
during REM sleep, in our present study, reflects changes within the 
thalamo-cortical regulatory network during REM sleep, caused by the 
attenuated inhibition of RT neurons by cholinergic afferents from the 
PPT, due to the PPT lesion. Moreover, these rearrangements within 
the thalamo-cortical regulatory network might be due to the tonically 
and sustainably decreased cholinergic inhibition of RT neurons and 
excitation of TC neurons across all sleep/wake states, particularly 
during REM sleep.
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